Testing effectiveness (Phase 2)Ended earlyNCT05297864
What this trial is testing
PARP Inhibition for Gliomas (PI-4G or π4g)
Who this might be right for
Recurrent GlioblastomaRecurrent AstrocytomaRecurrent Oligodendroglioma+1 more
University of Oklahoma 15